Literature DB >> 3933341

Dynamic changes in serum phosphorus levels in diabetic ketoacidosis.

R Kebler, F D McDonald, P Cadnapaphornchai.   

Abstract

The dynamic changes in serum phosphorus levels in 69 episodes of ketoacidosis in 48 diabetic patients were retrospectively evaluated. The mean age was 41 +/- 2 years (mean +/- SEM), and the duration of diabetes mellitus was 7 +/- 1 years. The serum phosphorus levels determined within the first six hours of admission were analyzed. Before initiation of therapy, the incidence of hyperphosphatemia was 94.7 percent. At the end of 12 hours, the mean serum phosphorus level fell from 9.2 +/- 0.6 to 2.8 +/- 0.3 mg/dl. Before therapy, the serum phosphorus level correlated positively with the serum glucose level, the effective plasma osmolality, and anion gaps, and correlated negatively with the serum chloride level. It is concluded that hyperphosphatemia is common in diabetic ketoacidosis before therapy. The increase in serum phosphorus is likely to be due to a transcellular shift. Potential factors responsible for the shift are serum glucose, through its osmotic effect, and the organic anions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933341     DOI: 10.1016/0002-9343(85)90053-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

Review 1.  Hyperphosphataemia: treatment options.

Authors:  Fabio Malberti
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

Review 2.  Management of diabetic ketoacidosis.

Authors:  T H Sanson; S N Levine
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 3.  Diabetes mellitus and electrolyte disorders.

Authors:  George Liamis; Evangelos Liberopoulos; Fotios Barkas; Moses Elisaf
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 4.  Respiratory failure in diabetic ketoacidosis.

Authors:  Nikifor K Konstantinov; Mark Rohrscheib; Emmanuel I Agaba; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  World J Diabetes       Date:  2015-07-25

5.  Prognostic Factors in Patients Hospitalized with Diabetic Ketoacidosis.

Authors:  Avinash Agarwal; Ambuj Yadav; Manish Gutch; Shuchi Consul; Sukriti Kumar; Ved Prakash; Anil Kumar Gupta; Annesh Bhattacharjee
Journal:  Endocrinol Metab (Seoul)       Date:  2016-09-01

6.  A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake.

Authors:  Kazuhito Fukuoka; Yuriko Sato; Hiroyuki Sakurai; Soko Kawashima; Shinya Kaname; Yoshihiro Arimura
Journal:  Kidney Int Rep       Date:  2017-02-14

Review 7.  Effects of diabetic ketoacidosis in the respiratory system.

Authors:  Alice Gallo de Moraes; Salim Surani
Journal:  World J Diabetes       Date:  2019-01-15

Review 8.  Strategies for Phosphate Control in Patients With CKD.

Authors:  Fellype Carvalho Barreto; Daniela Veit Barreto; Ziad A Massy; Tilman B Drüeke
Journal:  Kidney Int Rep       Date:  2019-06-20

9.  Severe osteomalacia with multiple insufficiency fractures secondary to intravenous iron therapy in a patient with Rendu-Osler-Weber syndrome.

Authors:  Eduardo Luis Callejas-Moraga; Enrique Casado; Marta Gomez-Nuñez; Ana Paula Caresia-Aroztegui
Journal:  Bone Rep       Date:  2020-08-22

10.  Phosphate and fibroblast growth factor 23 in diabetes.

Authors:  Amarens van der Vaart; Stanley M H Yeung; Peter R van Dijk; Stephan J L Bakker; Martin H de Borst
Journal:  Clin Sci (Lond)       Date:  2021-07-30       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.